However, the mRNA levels of ERCC1 and TS has been reported by Shirota Y et al. to be associated with survival of 5-FU and oxaliplatin adjuvant chemotherapy in CRC patients[20]. The gene discussed is ERCC1; the disease is colorectal carcinoma.